Sophiris Bio (SPHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,758 | -117 | -21,160 | -15,863 | -10,210 |
| Depreciation Amortization | 311 | 162 | 230 | 720 | 130 |
| Accounts receivable | 35 | -24 | 172 | 142 | N/A |
| Accounts payable and accrued liabilities | 555 | 1,553 | -1,006 | -637 | N/A |
| Other Working Capital | -606 | -3,609 | 570 | -429 | 460 |
| Other Operating Activity | 323 | -1,153 | 3,394 | 1,050 | 1,040 |
| Operating Cash Flow | $-2,140 | $-3,188 | $-17,800 | $-15,017 | $-8,580 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -3 | -20 | -26 | -20 |
| Other Investing Activity | 0 | 0 | 100 | 0 | 17 |
| Investing Cash Flow | $-3 | $-3 | $80 | $-26 | $-3 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | -1,801 | N/A |
| Debt Repayment | -2,878 | -1,422 | -3,190 | N/A | N/A |
| Common Stock Issued | N/A | -454 | 8,074 | 8,285 | N/A |
| Other Financing Activity | -1,040 | 0 | -1,144 | 0 | 7,120 |
| Financing Cash Flow | $-3,918 | $-1,876 | $3,740 | $6,484 | $7,120 |
| Exchange Rate Effect | -90 | -48 | 280 | 375 | 200 |
| Beginning Cash Position | 9,721 | 9,721 | 23,410 | 23,410 | 23,410 |
| End Cash Position | 3,570 | 4,606 | 9,720 | 15,226 | 22,150 |
| Net Cash Flow | $-6,151 | $-5,115 | $-13,690 | $-8,184 | $-1,250 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,140 | -3,188 | -17,800 | -15,017 | -8,580 |
| Capital Expenditure | -3 | -3 | -26 | -26 | N/A |
| Free Cash Flow | -2,143 | -3,191 | -17,826 | -15,043 | -8,580 |